PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 225,000 shares; 2025Q3: 125,000 shares; 2025Q4: 375,000 shares; 2026Q1: 285,000 shares; 2026Q2: 260,000 shares; 2026Q3: 425,000 shares 425,000 $124M 7.21% +165,000 Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,450,000 shares; 2025Q1: 1,600,000 shares; 2025Q2: 1,700,000 shares; 2025Q3: 1,750,000 shares; 2025Q4: 2,000,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 700,000 shares; 2026Q3: 600,000 shares 600,000 $123M 7.17% -100,000 Timeline IDYA IDEAYA BIOSCIENCES INC More: the full row for IDEAYA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,000,000 shares; 2025Q1: 3,500,000 shares; 2025Q2: 3,345,000 shares; 2025Q3: 2,250,000 shares; 2025Q4: 3,125,000 shares; 2026Q1: 3,450,000 shares; 2026Q2: 3,000,000 shares; 2026Q3: 2,850,000 shares 2,850,000 $109M 6.38% -150,000 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,500,000 shares; 2025Q1: 13,000,000 shares; 2025Q2: 15,000,000 shares; 2025Q3: 15,150,000 shares; 2025Q4: 13,000,000 shares; 2026Q1: 11,150,000 shares; 2026Q2: 12,150,000 shares; 2026Q3: 5,900,000 shares 5,900,000 $86.5M 5.04% -6,250,000 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 415,000 shares; 2025Q4: 400,000 shares; 2026Q1: 675,000 shares; 2026Q2: 1,024,000 shares; 2026Q3: 870,000 shares 870,000 $86.1M 5.02% -154,000 Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 200,000 shares; 2026Q1: 575,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 975,000 shares 975,000 $69.1M 4.03% -25,000 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,000 shares; 2025Q1: 394,342 shares; 2025Q2: 700,000 shares; 2025Q3: 450,000 shares; 2025Q4: 510,000 shares; 2026Q1: 560,000 shares; 2026Q2: 875,000 shares; 2026Q3: 1,015,000 shares 1,015,000 $66.4M 3.87% +140,000 Timeline BNTX BIONTECH SE More: the full row for BIONTECH SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 200,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,015,000 shares; 2026Q3: 650,000 shares 650,000 $63.9M 3.72% -365,000 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 950,000 shares; 2025Q4: 4,200,000 shares; 2026Q1: 3,000,000 shares; 2026Q2: 2,850,000 shares; 2026Q3: 2,150,000 shares 2,150,000 $53.6M 3.12% -700,000 Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 85,000 shares; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $50.4M 2.93% new Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 140,000 shares; 2025Q1: 240,000 shares; 2025Q2: 350,000 shares; 2025Q3: 340,000 shares; 2025Q4: 340,000 shares; 2026Q1: 540,000 shares; 2026Q2: 465,000 shares; 2026Q3: 1,080,000 shares 1,080,000 $49.5M 2.88% +615,000 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 450,000 shares; 2025Q1: 500,000 shares; 2025Q2: 1,900,000 shares; 2025Q3: 2,400,000 shares; 2025Q4: 1,250,000 shares; 2026Q1: 1,400,000 shares; 2026Q2: 2,550,000 shares; 2026Q3: 3,000,000 shares 3,000,000 $48.3M 2.81% +450,000 Timeline ACHV ACHIEVE LIFE SCIENCE INC More: the full row for ACHIEVE LIFE SCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,425,000 shares; 2026Q3: 5,951,032 shares 5,951,032 $48.1M 2.8% +526,032 Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,500,000 shares; 2025Q1: 2,300,000 shares; 2025Q2: 2,200,000 shares; 2025Q3: 3,250,000 shares; 2025Q4: 3,500,000 shares; 2026Q1: 3,850,000 shares; 2026Q2: 5,300,000 shares; 2026Q3: 6,000,000 shares 6,000,000 $46M 2.68% +700,000 Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares; 2025Q4: 315,000 shares; 2026Q1: 400,000 shares; 2026Q2: 800,000 shares; 2026Q3: 500,000 shares 500,000 $44M 2.56% -300,000 Timeline AVBP ARRIVENT BIOPHARMA INC More: the full row for ARRIVENT BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 350,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,350,000 shares 1,350,000 $40.9M 2.38% +350,000 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 500,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 900,000 shares; 2026Q3: 1,250,000 shares 1,250,000 $40M 2.33% +350,000 Timeline NBIX NEUROCRINE BIOSCIENCES INC More: the full row for NEUROCRINE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,000 shares; 2025Q1: not reported; 2025Q2: 150,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000 $35.5M 2.07% new Timeline BLTE BELITE BIO INC More: the full row for BELITE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 250,000 shares; 2026Q3: 200,000 shares 200,000 $34M 1.98% -50,000 Timeline AXSM AXSOME THERAPEUTICS INC. More: the full row for AXSOME THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 175,000 shares 175,000 $32.3M 1.88% new Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 700,000 shares; 2025Q1: 425,000 shares; 2025Q2: 850,000 shares; 2025Q3: 850,000 shares; 2025Q4: 600,000 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $31.3M 1.82% +500,000 Timeline OLMA OLEMA PHARMACEUTICALS INC More: the full row for OLEMA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,208,875 shares; 2025Q1: 3,208,875 shares; 2025Q2: 3,208,875 shares; 2025Q3: 3,208,875 shares; 2025Q4: 3,208,875 shares; 2026Q1: 3,208,875 shares; 2026Q2: 3,208,875 shares; 2026Q3: 3,208,875 shares 3,208,875 $27.7M 1.61% 0 Timeline MAZE MAZE THERAPEUTICS INC More: the full row for MAZE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 936,914 shares; 2025Q2: 611,914 shares; 2025Q3: 1,227,300 shares; 2025Q4: 950,000 shares; 2026Q1: 1,235,000 shares; 2026Q2: 1,935,000 shares; 2026Q3: 935,000 shares 935,000 $25.4M 1.48% -1,000,000 Timeline PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 525,000 shares; 2026Q3: 750,000 shares 750,000 $24.2M 1.41% +225,000 Timeline APMD APNIMED INC More: the full row for APNIMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,100,000 shares 1,100,000 $24.1M 1.4% new Timeline YARW YARROW BIOSCIENCE INC More: the full row for YARROW BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,026,258 shares 1,026,258 $23.1M 1.35% new Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,250,000 shares; 2025Q1: 424,715 shares; 2025Q2: 850,000 shares; 2025Q3: 2,200,000 shares; 2025Q4: 1,550,000 shares; 2026Q1: 2,400,000 shares; 2026Q2: 1,880,000 shares; 2026Q3: 1,445,000 shares 1,445,000 $20.7M 1.21% -435,000 Timeline MANE VERADERMICS INC More: the full row for VERADERMICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 25,000 shares; 2026Q2: 180,000 shares; 2026Q3: 170,000 shares 170,000 $20.6M 1.2% -10,000 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 875,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,200,000 shares; 2026Q3: 600,000 shares 600,000 $19.4M 1.13% -1,600,000 Timeline ODTX ODYSSEY THERAPEUTICS INC More: the full row for ODYSSEY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 521,736 shares; 2026Q3: 846,148 shares 846,148 $18.8M 1.09% +324,412 Timeline SRPT SAREPTA THERAPEUTICS INC More: the full row for SAREPTA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,000,000 shares 1,000,000 $18.2M 1.06% new Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 350,000 shares; 2025Q2: 200,000 shares; 2025Q3: not reported; 2025Q4: 1,750,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 2,675,000 shares; 2026Q3: 1,500,000 shares 1,500,000 $17.6M 1.02% -1,175,000 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 575,000 shares; 2025Q3: 850,000 shares; 2025Q4: 850,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 600,000 shares; 2026Q3: 500,000 shares 500,000 $15.1M 0.88% -100,000 Timeline BHVN BIOHAVEN LTD More: the full row for BIOHAVEN LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 700,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,100,000 shares 1,100,000 $14.7M 0.86% new Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,066,212 shares 1,066,212 $14.6M 0.85% new Timeline CRSP CRISPR THERAPEUTICS AG More: the full row for CRISPR THERAPEUTICS AG Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 300,000 shares; 2026Q3: 250,000 shares 250,000 $13.8M 0.81% -50,000 Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 80,000 shares; 2026Q3: 350,000 shares 350,000 $13.3M 0.78% +270,000 Timeline ENTX ENTERA BIO LTD More: the full row for ENTERA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,411,764 shares 4,411,764 $12.8M 0.75% new Timeline DSGN DESIGN THERAPEUTICS INC More: the full row for DESIGN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,217,627 shares; 2025Q1: 4,217,627 shares; 2025Q2: 4,217,627 shares; 2025Q3: 3,655,000 shares; 2025Q4: 2,500,000 shares; 2026Q1: 1,950,000 shares; 2026Q2: 3,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $12.6M 0.73% -2,000,000 Timeline CBIO CRESCENT BIOPHARMA INC. More: the full row for CRESCENT BIOPHARMA INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 553,686 shares; 2025Q3: 600,000 shares; 2025Q4: 600,000 shares; 2026Q1: 482,500 shares; 2026Q2: 1,900,000 shares; 2026Q3: 850,000 shares 850,000 $12.4M 0.72% -1,050,000 Timeline ETRA ELECTRA THERAPEUTICS INC More: the full row for ELECTRA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,000,000 shares 1,000,000 $11.2M 0.66% new Timeline NERV MINERVA NEUROSCIENCES INC More: the full row for MINERVA NEUROSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,311,000 shares; 2026Q1: 3,215,000 shares; 2026Q2: 3,288,777 shares; 2026Q3: 3,288,777 shares 3,288,777 $11M 0.64% 0 Timeline LBRX LB PHARMACEUTICALS INC More: the full row for LB PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,130,000 shares; 2025Q4: 1,200,000 shares; 2026Q1: 915,000 shares; 2026Q2: 585,000 shares; 2026Q3: 250,000 shares 250,000 $9.6M 0.56% -335,000 Timeline ATTO ATTOVIA THERAPEUTICS INC More: the full row for ATTOVIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 391,426 shares 391,426 $6.71M 0.39% new Timeline VKTX VIKING THERAPEUTICS INC More: the full row for VIKING THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $6.52M 0.38% new Timeline EDIT EDITAS MEDICINE INC More: the full row for EDITAS MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,222,000 shares; 2026Q3: 2,222,000 shares 2,222,000 $5.71M 0.33% 0 Timeline TNXP TONIX PHARMACEUTICALS HLDG C More: the full row for TONIX PHARMACEUTICALS HLDG C Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 550,000 shares 550,000 $5.36M 0.31% new Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,000,000 shares 1,000,000 $4.84M 0.28% new Timeline VOGX VOGENX INC More: the full row for VOGENX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 205,000 shares 205,000 $4.67M 0.27% new Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 275,000 shares; 2025Q2: 275,000 shares; 2025Q3: 275,000 shares; 2025Q4: 1,375,000 shares; 2026Q1: 1,075,000 shares; 2026Q2: 665,000 shares; 2026Q3: 85,000 shares 85,000 $2.87M 0.17% -580,000 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 625,000 shares; 2025Q3: 625,000 shares; 2025Q4: 395,000 shares; 2026Q1: 400,000 shares; 2026Q2: 1,125,000 shares; 2026Q3: 200,000 shares 200,000 $2.81M 0.16% -925,000 Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 963,855 shares; 2026Q3: 963,855 shares 963,855 $2.63M 0.15% 0 Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $2.5M 0.15% new Timeline UNCY UNICYCIVE THERAPEUTICS INC More: the full row for UNICYCIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 473,562 shares; 2025Q3: 473,563 shares; 2025Q4: 473,563 shares; 2026Q1: 473,563 shares; 2026Q2: 473,563 shares; 2026Q3: 473,563 shares 473,563 $2.22M 0.13% 0 Timeline PTN PALATIN TECHNOLOGIES INC More: the full row for PALATIN TECHNOLOGIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 140,000 shares; 2026Q1: 140,000 shares; 2026Q2: 130,000 shares; 2026Q3: 129,260 shares 129,260 $1.15M 0.07% -740 Timeline JATT JATT II ACQUISITION CORP More: the full row for JATT II ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $1.12M 0.07% 0 Timeline JTTT JATT III ACQUISITION CORP More: the full row for JATT III ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $1.1M 0.06% new Timeline RACC RESEARCH ALLIANCE CORP III More: the full row for RESEARCH ALLIANCE CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $1.08M 0.06% 0 Timeline SEPN SEPTERNA INC More: the full row for SEPTERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 134,202 shares; 2025Q1: 134,202 shares; 2025Q2: 109,202 shares; 2025Q3: 83,548 shares; 2025Q4: 23,548 shares; 2026Q1: 23,548 shares; 2026Q2: 23,548 shares; 2026Q3: 23,548 shares 23,548 $921K 0.05% 0 Timeline AMAN AMANAT ACQUISITION CORP More: the full row for AMANAT ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares; 2026Q3: 50,000 shares 50,000 $534K 0.03% 0 Timeline LGVN LONGEVERON INC More: the full row for LONGEVERON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 192,308 shares 192,308 $517K 0.03% new Timeline GUTS FRACTYL HEALTH INC More: the full row for FRACTYL HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 500,000 shares; 2025Q4: 1,100,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 504,965 shares 504,965 $275K 0.02% -495,035 Timeline